Home > Insider Trading > Filing (0001181431-10-040001)

Filing Details

Accession Number:: 0001181431-10-040001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-08-03 13:00:00
Reporting Period:: 2010-07-30

Filing Date:: 2010-08-03
Accepted Time:: 2010-08-03 17:33:35
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1174940	Oragenics Inc	ORNI	Pharmaceutical Preparations (2834)	593410522

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1234877	Beverly Koski	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No
1234878	L Christine Koski	1500 West University Parkway Sarasota FL 34243	Yes	No	Yes	No
1234879	Koski Family Lp	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No
1234880	C Robert Koski	1500 West University Parkway Sarasota FL 34243	Yes	No	Yes	No
1234881	L Thomas Koski	1500 West University Parkway Sarasota FL 34243	No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2010-07-30	5,000,000	$0.40	59,960,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	893,333	Direct
Common Stock	453,333	Direct
Common Stock	1,393,334	Direct
Common Stock	1,400,000	Indirect	By Trust
Common Stock	40,000	Indirect	By Koski Management, Inc.

Footnotes

The Company entered into a Common Stock Purchase Agreement (the "Agreement") with the Koski Family Limited Partnership. Pursuant to the terms of the Agreement, the Company issued 5.0 million shares of its Common Stock to the Koski Family Limited Partnership at a price of $0.40 per share. The $2.0 million aggregate consideration paid by the Koski Family Limited Partnership consisted of (i) $1,000,000 cash, and (ii) the exchange and cancellation of the outstanding $1.0 million promissory note issued to the Koski Family Limited Partnership on May 25, 2010.
Shares owned directly by Koski Family Limited Partnership. Shares owned indirectly by Beverly Koski (through Koski Management, Inc.), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
Shares owned directly by Christine L. Koski.
Shares owned directly by Robert C. Koski.
Shares owned directly by Thomas L. Koski.
Shares owned by trusts of which Robert C. Koski is trustee. Such trusts are the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (200,000 shares); The Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (500,000 shares); The Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (500,000 shares); and The Robert Clayton Koski Trust for the benefit of Robert Edward Koski (200,000 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
Shares owned indirectly by Beverly Koski (through Koski Management, Inc).